72 related articles for article (PubMed ID: 5572349)
1. An experimental tumour model for the study of the effects of chemotherapy and immunotherapy in combination with surgery.
Winsey HS; Mathé G; Thompson R
Br J Surg; 1971 Apr; 58(4):303. PubMed ID: 5572349
[No Abstract] [Full Text] [Related]
2. Evaluation of surgery, chemotherapy and immunotherapy on Lewis lung tumour.
Thompson RB; Alberola V; Mathé G
Rev Eur Etud Clin Biol; 1972 Nov; 17(9):900-2. PubMed ID: 4653992
[No Abstract] [Full Text] [Related]
3. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
4. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
DeWys WD
Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
[No Abstract] [Full Text] [Related]
5. Control of Lewis lung carcinoma by combined treatment with local hyperthermia and cyclophosphamide: preliminary results.
Yerushalmi A; Hazan G
Isr J Med Sci; 1979 May; 15(5):462-3. PubMed ID: 447517
[No Abstract] [Full Text] [Related]
6. Chemotherapy, BCG, and serum from tumor-bearing mice: comparative effects on growth and spread of mouse Lewis lung cancer.
Greager JA; Culberson G; Manning B; Das Cupta TK
Arch Surg; 1975 Aug; 110(8):901-2. PubMed ID: 1156156
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
Poste G; Kirsh R
Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
[No Abstract] [Full Text] [Related]
8. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic osteosarcoma by cyclophosphamide and radiotherapy.
Schaeffer J; el-Mahdi AM; Constable WC
Radiology; 1974 May; 111(2):467-9. PubMed ID: 4522475
[No Abstract] [Full Text] [Related]
10. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
Kedar E; Chriqui-Zeira E; Kyriazis AP
J Biol Response Mod; 1984 Oct; 3(5):517-26. PubMed ID: 6334139
[TBL] [Abstract][Full Text] [Related]
11. DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
Lim DS; Kim JH; Lee DS; Yoon CH; Bae YS
Cancer Immunol Immunother; 2007 Nov; 56(11):1817-29. PubMed ID: 17443323
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
Mattern J; Jaeger S; Wayss K; Volm M
Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
[TBL] [Abstract][Full Text] [Related]
13. Effect of sequence of combined radiation and cyclophosphamide regimens on murine osteosarcoma.
El-Mahdi AM; Shaeffer J
Cancer Treat Rep; 1977 Nov; 61(8):1569-71. PubMed ID: 270390
[No Abstract] [Full Text] [Related]
14. [Treatment of spontaneous metastatic lung cancer with interleukin-12 gene-modified dendritic cells vaccine].
Chen JQ; Xiu QY; Shen C; Yan ZM
Ai Zheng; 2002 Dec; 21(12):1328-31. PubMed ID: 12520741
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
16. [Development of an experimental model for the study of the effects of cryotherapy on lung tumours].
Forest V; Campos L; Péoc'h M; Guyotat D; Vergnon JM
Pathol Biol (Paris); 2005 May; 53(4):199-203. PubMed ID: 15850952
[TBL] [Abstract][Full Text] [Related]
17. The in vivo distribution of transferred syngeneic, allogeneic, and xenogeneic lymphoid cells: implication for the adoptive immunotherapy of tumors.
Mathisen DJ; Rosenberg SA
J Immunol; 1980 May; 124(5):2295-300. PubMed ID: 7365258
[No Abstract] [Full Text] [Related]
18. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
20. Rotational stress reduces the effectiveness of antitumor drugs in mice.
Giraldi T; Perissin L; Zorzet S; Rapozzi V
Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
